These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
709 related items for PubMed ID: 15467532
1. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532 [Abstract] [Full Text] [Related]
2. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, West DW, Whittemore AS. Am J Epidemiol; 2004 Oct 01; 160(7):613-8. PubMed ID: 15383404 [Abstract] [Full Text] [Related]
3. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer. Greer JB, Modugno F, Allen GO, Ness RB. Obstet Gynecol; 2005 Apr 01; 105(4):731-40. PubMed ID: 15802398 [Abstract] [Full Text] [Related]
4. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR. Gynecol Oncol; 2001 Dec 01; 83(3):575-85. PubMed ID: 11733975 [Abstract] [Full Text] [Related]
5. Anthropometry and the risk of epithelial ovarian cancer. Greer JB, Modugno F, Ness RB, Allen GO. Cancer; 2006 May 15; 106(10):2247-57. PubMed ID: 16596653 [Abstract] [Full Text] [Related]
6. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Rosenblatt KA, Thomas DB. Cancer Epidemiol Biomarkers Prev; 1996 Nov 15; 5(11):933-5. PubMed ID: 8922304 [Abstract] [Full Text] [Related]
7. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Am J Epidemiol; 2007 Oct 15; 166(8):894-901. PubMed ID: 17656616 [Abstract] [Full Text] [Related]
8. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR. Cancer Res; 1988 Oct 15; 48(20):5849-52. PubMed ID: 3167840 [Abstract] [Full Text] [Related]
9. Hormone replacement therapy and risk of epithelial ovarian cancer. Purdie DM, Bain CJ, Siskind V, Russell P, Hacker NF, Ward BG, Quinn MA, Green AC. Br J Cancer; 1999 Oct 15; 81(3):559-63. PubMed ID: 10507786 [Abstract] [Full Text] [Related]
10. Oral contraceptives and epithelial ovarian cancer. Does dose matter? Sanderson M, Williams MA, Weiss NS, Hendrix NW, Chauhan SP. J Reprod Med; 2000 Sep 15; 45(9):720-6. PubMed ID: 11027080 [Abstract] [Full Text] [Related]
11. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Riman T, Nilsson S, Persson IR. Acta Obstet Gynecol Scand; 2004 Sep 15; 83(9):783-95. PubMed ID: 15315588 [Abstract] [Full Text] [Related]
14. Risk factors for ovarian cancer in central Italy. Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C. Gynecol Oncol; 2000 Oct 15; 79(1):50-4. PubMed ID: 11006030 [Abstract] [Full Text] [Related]
15. Risk factors for benign serous and mucinous epithelial ovarian tumors. Jordan SJ, Green AC, Whiteman DC, Webb PM. Obstet Gynecol; 2007 Mar 15; 109(3):647-54. PubMed ID: 17329516 [Abstract] [Full Text] [Related]